BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 12:41 pm
Intimation of Closure of Trading Window
Kwality Pharmaceuticals Ltd · 539997
✦ AI Summary
Kwality Pharmaceuticals Ltd has announced the closure of its trading window for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
f2d83aae-6b74-4fa0-8d8b-2a95cb4ad9d1.pdf
View document text
Date: September 28, 2026
The Department of Corporate Services,
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai – 400001.
BSE Scrip Code: 539997
SUBJECT: INTIMATION OF CLOSURE OF TRADING WINDOW
Dear Sir/ Madam,
Pursuant to SEBI( Prohibition of Insider Trading) Regulations, 2015 as amended from time to time read
with Company’s Code of Conduct for Prevention of Insider Trading in securities, the trading window for
dealing in Equity Shares of the Company for all Designated Persons and their Immediate Relatives
covered under Company’s Code of Conduct for prevention of Insider Trading in Securities shall remain
closed from Thursday, October 1, 2026 till 48 hours after the declaration of Unaudited Financial
Results of the Company for the Quarter and Half year ended September 30, 2026.
Accordingly, all Designated Persons and their Immediate Relatives have been advised not to deal in the
Equity Shares of the Company during the aforesaid period of closure of the Trading Window.
The date of Board Meeting of the Company for consideration and declaration of the of the Unaudited
Financial Results for the Quarter and Half year ended September 30, 2026 shall be intimated separately in
due course.
Kindly take the above information on record.
Thanking you.
Yours faithfully,
For KWALITY PHARMACEUTICALS LIMITED
RAMESH KUMAR
Managing Director
DIN: 00462656